XML 63 R79.htm IDEA: XBRL DOCUMENT v3.19.3
Stockholders' Equity and Noncontrolling Interests - Stock-Based Compensation Information (Detail) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Stock Appreciation Rights          
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]          
Beginning balance, shares     335    
Forfeited, shares     (269)    
Ending balance, shares 66   66    
Weighted-Average Grant Date Fair Value, Beginning balance     $ 84.41    
Weighted-Average Grant Date Fair Value, Expired     77.90    
Weighted-Average Grant Date Fair Value, Ending balance $ 110.83   $ 110.83    
Weighted-average contractual remaining life (in years)     17 days    
Exercisable shares 66   66    
Weighted-average exercise price     $ 110.83    
Weighted-average exercise price exercisable shares $ 110.83   $ 110.83    
Compensation expense (credit) $ 1,000 $ 7,000 $ (14,000) $ (27,000)  
Fair value of liability award $ 1,000   $ 1,000   $ 33,000
Restricted Stock Awards          
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]          
Beginning balance, shares     10,000    
Ending balance, shares 10,000   10,000    
Weighted-Average Grant Date Fair Value, Beginning balance     $ 80.05    
Weighted-Average Grant Date Fair Value, Ending balance $ 80.05   $ 80.05    
Weighted-average contractual remaining life (in years)     3 years 5 months 1 day    
Weighted-average exercise price     $ 80.05    
Compensation expense (credit) $ 20,000 24,000 $ 60,000 308,000  
Restricted Stock Units          
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]          
Beginning balance, shares     18,316    
Granted, shares     8,250    
Exercised, shares     (18,316)    
Ending balance, shares 8,250   8,250    
Weighted-Average Grant Date Fair Value, Beginning balance     $ 111.12    
Weighted-Average Grant Date Fair Value, Granted     113.19    
Weighted-Average Grant Date Fair Value, Exercised     111.12    
Weighted-Average Grant Date Fair Value, Ending balance $ 113.19   $ 113.19    
Weighted-average contractual remaining life (in years)     17 days    
Weighted-average exercise price     $ 111.12    
Compensation expense (credit) $ 154,000 $ 371,000 $ 1,094,000 $ 920,000  
Fair value of liability award $ 1,021,000   $ 1,021,000   $ 2,426,000